Preoperative treatment of thyrotoxicosis in developing countries: a comparative study of carbimazole and propranolol

Preoperative management of treatment in thyrotoxicosis was investigated in a comparative study of carbimazole and propranolol in 41 consecutive patients collected during a 3-year period. The groups included 20 and 21 patients respectively, of equal sex and age distribution and of similar severity. T...

Full description

Saved in:
Bibliographic Details
Published inAnnals of the Royal College of Surgeons of England Vol. 70; no. 6; pp. 357 - 360
Main Authors Haddad, J F, Tibblin, S
Format Journal Article
LanguageEnglish
Published England Royal College of Surgeons of England 01.11.1988
Subjects
Adolescent
Adult
Carbimazole - therapeutic use
Child
Developing Countries
Female
Humans
Male
Middle Aged
Preoperative Care
Propranolol - therapeutic use
Thyrotoxicosis - drug therapy
Thyrotoxicosis - surgery
Time Factors
Online AccessGet full text

Cover

More Information
Summary:Preoperative management of treatment in thyrotoxicosis was investigated in a comparative study of carbimazole and propranolol in 41 consecutive patients collected during a 3-year period. The groups included 20 and 21 patients respectively, of equal sex and age distribution and of similar severity. The length of the preoperative treatment was significantly reduced in the propranolol pretreated patients (P greater than 0.001). Intraoperative blood loss, postoperative function with regard to the thyroid, parathyroids and vocal cords were similar in both groups. Three and two patients respectively had permanent hypothyroidism requiring thyroxin treatment. In patients with therapy compliance problems treatment with propranolol would entail a definite advantage, particularly in developing countries.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0035-8843
1478-7083